VS

Virendra Singh Panwar

Director Director DIN 00068450
DIN 00068450 First appointment Apr 2006 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2006
Shareholding value Locked Premium profile

About Virendra Singh Panwar

Virendra Singh Panwar has 20 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 00068450
Primary Designation Director
First Appointment 07 Apr 2006
Oldest Company Age 28 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Amend Drugs Private Limited U24232MP1998PTC012988
Director 07 Apr 2006 1998 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Amend Drugs Private Limited
Premium access

Shareholding and investment profile for Virendra Singh Panwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Virendra Singh Panwar

Virendra Singh Panwar has 20 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Virendra Singh Panwar is associated with 0 companies as Director.

Virendra Singh Panwar has expertise in General Business.

Virendra Singh Panwar has 20 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available